|
1
|
Tzoumpa S, Ingen-Housz-Oro S, de Masson A, Pham-Ledard A, El Aarbaoui T, Dereure O, Quereux G, Faiz S, de Vicq de Cumptich M, Ram-Wolff C, Janela-Lapert R, Guenova E, Lheure C, Le Corre Y, Adamski H, Blanchard M, Bonnet N, Amatore F, Grange F, Troin L, Bagot M, Beylot-Barry M. Evolution of patients with Sézary syndrome after mogamulizumab discontinuation for any cause except progression: a multicenter retrospective study (Moga-stop study). Br J Dermatol 2024:ljae153. [PMID: 38660811 DOI: 10.1093/bjd/ljae153] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2024] [Revised: 03/30/2024] [Accepted: 04/24/2024] [Indexed: 04/26/2024]
Abstract
The results of this study suggest that a progressive discontinuation of mogamulizumab should be considered once response is obtained in Sezary syndrome patients, even after a treatment of short-duration. This may possibly minimize the risk of adverse effects, costs, and resistance to mogamulizumab. Additionally, our study emphasizes that mogamulizumab rechallenge should be encouraged as first-choice for relapsing patients.
Collapse
Affiliation(s)
- Sofia Tzoumpa
- Department of Dermatology, Henri-Mondor University Hospital, AP-HP , Créteil, France
| | - Saskia Ingen-Housz-Oro
- Department of Dermatology, Henri-Mondor University Hospital, AP-HP , Créteil, France
- Paris Est Créteil University, EpiDermE, Créteil, France
- French Cutaneous Lymphomas Study Group (GFELC), France
| | - Adèle de Masson
- Department of Dermatology, Saint-Louis University Hospital, AP-HP, Université Paris Cité, Paris, France
- French Cutaneous Lymphomas Study Group (GFELC), France
| | - Anne Pham-Ledard
- Department of Dermatology, INSERM 1312, Bordeaux University Hospital, Bordeaux, France
- French Cutaneous Lymphomas Study Group (GFELC), France
| | | | - Olivier Dereure
- Department of Dermatology, Montpellier University Hospital, Montpellier, France
- French Cutaneous Lymphomas Study Group (GFELC), France
| | - Gaëlle Quereux
- Department of Dermatology, CHU Nantes, Nantes University, CIC 1413, INSERM, CNRS, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302, Nantes, France
- French Cutaneous Lymphomas Study Group (GFELC), France
| | - Sarah Faiz
- Department of Dermatology, Lille University Hospital, Lille, France
- French Cutaneous Lymphomas Study Group (GFELC), France
| | - Marine de Vicq de Cumptich
- Department of Dermatology, Saint-Pierre, Brugmann University Hospitals, Brussels, Belgium and Department of Hematology Bordet Institute, Brussels, Belgium
- French Cutaneous Lymphomas Study Group (GFELC), France
| | - Caroline Ram-Wolff
- Department of Dermatology, Saint-Louis University Hospital, AP-HP, Université Paris Cité, Paris, France
- French Cutaneous Lymphomas Study Group (GFELC), France
| | - Raphaël Janela-Lapert
- Department of Dermatology, Rouen University Hospital, Rouen, France
- French Cutaneous Lymphomas Study Group (GFELC), France
| | - Emmanuella Guenova
- Department of Dermatology, Lausanne University Hospital, and Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland
- French Cutaneous Lymphomas Study Group (GFELC), France
| | - Coralie Lheure
- Department of Dermatology, Cochin University Hospital, AP-HP, Paris, France
- French Cutaneous Lymphomas Study Group (GFELC), France
| | - Yannick Le Corre
- Department of Dermatology, Angers University Hospital, Angers, France
- French Cutaneous Lymphomas Study Group (GFELC), France
| | - Henri Adamski
- Department of Dermatology, Rennes University Hospital, Rennes, France
- French Cutaneous Lymphomas Study Group (GFELC), France
| | - Maël Blanchard
- Department of Dermatology, Lausanne University Hospital, and Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland
- Division of Dermatology and Venereology, Geneva University Hospitals, Geneva, Switzerland
- French Cutaneous Lymphomas Study Group (GFELC), France
| | - Nathalie Bonnet
- Department of Dermatology, Hôpital Nord, AP-HM, Marseille, France
- French Cutaneous Lymphomas Study Group (GFELC), France
| | - Florent Amatore
- Department of Dermatology, Hôpital Nord, AP-HM, Marseille, France
- French Cutaneous Lymphomas Study Group (GFELC), France
| | - Florent Grange
- Department of Dermatology, Centre Hospitalier de Valence, Valence, France
- French Cutaneous Lymphomas Study Group (GFELC), France
| | - Laura Troin
- Department of Dermatology, Nice University Hospital, Nice, France
- French Cutaneous Lymphomas Study Group (GFELC), France
| | - Martine Bagot
- Department of Dermatology, Saint-Louis University Hospital, AP-HP, Université Paris Cité, Paris, France
- French Cutaneous Lymphomas Study Group (GFELC), France
| | - Marie Beylot-Barry
- Department of Dermatology, INSERM 1312, Bordeaux University Hospital, Bordeaux, France
- French Cutaneous Lymphomas Study Group (GFELC), France
| |
Collapse
|
|
4
|
Janela-Lapert R, Dubray B, Duval-Modeste A, Castel M. [Treatment of advanced basal cell carcinoma with vismodegib followed by radiotherapy]. Ann Dermatol Venereol 2020; 147:780-782. [PMID: 32505377 DOI: 10.1016/j.annder.2020.04.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2020] [Revised: 04/18/2020] [Accepted: 04/28/2020] [Indexed: 10/24/2022]
Affiliation(s)
- R Janela-Lapert
- Service de dermatologie, Institut national de la santé et de la recherche médicale U1234, Rouen university hospital, université de Normandie, Rouen, France.
| | - B Dubray
- Service de radiothérapie, centre Henri Becquerel, Rouen, France
| | - A Duval-Modeste
- Service de dermatologie, Institut national de la santé et de la recherche médicale U1234, Rouen university hospital, université de Normandie, Rouen, France
| | - M Castel
- Service de dermatologie, Institut national de la santé et de la recherche médicale U1234, Rouen university hospital, université de Normandie, Rouen, France
| |
Collapse
|